New osteoporosis drug safety checked in indian women
NCT ID NCT06079476
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested the safety of romosozumab (Evenity) in 100 postmenopausal women in India who have osteoporosis and a high risk of bone fractures. Researchers tracked side effects, serious events, and changes in lab tests and vital signs. They also measured bone density changes in the spine and hip. The goal was to see if the drug is safe and tolerable for this group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Romosozumab (Evenity)
What this could lead to
If successful, this could confirm that romosozumab is a safe option for treating osteoporosis and reducing fracture risk in postmenopausal women in India.
What could go wrong
This is a small, completed Phase 4 safety study, not designed to prove effectiveness. Results may not apply to other populations, and rare side effects may not be detected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Apollo Hospital
New Delhi, National Capital Territory of Delhi, 110076, India
-
Christain Medical College
Vellore, Tamil Nadu, 632004, India
-
King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
Mumbai, Maharashtra, 400012, India
-
King Georges Medical University
Lucknow, Uttar Pradesh, 226 003, India
-
MGM Healthcare
Chennai, Tamil Nadu, 600 029, India
-
MS Ramaiah Medical College and Hospitals
Bangalore, Karnataka, 560054, India
-
Post Graduate Institute of Medical Education and Research
Chandigarh, Punjab, 160 012, India
-
Sancheti Institute for Orthopedics and rehabilitation
Pune, Maharashtra, 411005, India
-
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, 110060, India
-
Stavya Spine Hospital and Research Institute SSHRI
Ahmedabad, Gujarat, 380 007, India